Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study

Jamie N. Justice; Anoop M. Nambiar; Tamar Tchkonia; Nathan K. LeBrasseur; Rodolfo M. Pascual; Shahrukh Hashmi; Larissa Prata; Michał M. Masternak; Stephen B. Kritchevsky; Nicolas Musi; James L. Kirkland

doi:10.1016/j.ebiom.2018.12.052

Keywords

MedicineIdiopathic pulmonary fibrosisPulmonary fibrosisOpen labelFibrosisPathologyInternal medicineLungClinical trial

Affiliated Institutions

Related Publications

Histologic Spectrum of Idiopathic Interstitial Pneumonias

Daniel W. Visscher

Histopathologic classification plays a key role in separating multiple forms of idiopathic interstitial pneumonia into clinically meaningful categories with important difference...

2006 Proceedings of the American Thoracic ... 137 citations

Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease

Oliver Distler , Kristin B. Highland , Martina Gahlemann +12 more

Among patients with ILD associated with systemic sclerosis, the annual rate of decline in FVC was lower with nintedanib than with placebo; no clinical benefit of nintedanib was ...

2019 New England Journal of Medicine 1463 citations

Predicting Survival in Idiopathic Pulmonary Fibrosis

Talmadge E. King , Janet A. Tooze , Marvin I. Schwarz +2 more

Our purpose was to identify clinical, radiological and physiological (CRP) determinants of survival and to develop a CRP scoring system that predicts survival in newly diagnosed...

2001 American Journal of Respiratory and C... 842 citations

Expression and localization of tumor necrosis factor-alpha and its mRNA in idiopathic pulmonary fibrosis.

P F Piguet , C Ribaux , Vildan Karpuz +2 more

The expression of tumor necrosis factor alpha and its mRNA was investigated in surgical biopsies from idiopathic pulmonary fibrosis by immunohistochemistry, in situ hybridizatio...

1993 PubMed 189 citations

Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis.

Kathy B. Baumgartner , James M. Samet , Christine A. Stidley +2 more

We conducted a multicenter case-control study of clinically and histologically diagnosed idiopathic pulmonary fibrosis (IPF), a chronic diffuse interstitial lung disease of unkn...

1997 American Journal of Respiratory and C... 744 citations

Publication Info

Year: 2019
Type: article
Volume: 40
Pages: 554-563
Citations: 1063
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

1063

OpenAlex

Cite This

APA Style

                            
                                    Jamie N. Justice, 
                                
                                    Anoop M. Nambiar, 
                                
                                    Tamar Tchkonia
                                
                                et al.
                            
                            (2019). 
                            Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study. 
                            EBioMedicine
                            , 40
                            
                            , 554-563.
                            https://doi.org/10.1016/j.ebiom.2018.12.052

Identifiers

DOI: 10.1016/j.ebiom.2018.12.052